Detalhe da pesquisa
1.
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA-PegIFN study).
Br J Haematol
; 200(2): 175-186, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36214090
2.
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients.
Br J Haematol
; 194(2): 393-402, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34195988
3.
Longer treatment duration and history of osteoarticular symptoms predispose to tyrosine kinase inhibitor withdrawal syndrome.
Br J Haematol
; 187(3): 337-346, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31271217
4.
Discontinuation of dasatinib or nilotinib in chronic myeloid leukemia: interim analysis of the STOP 2G-TKI study.
Blood
; 129(7): 846-854, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932374
5.
Prognosis of patients with chronic myeloid leukemia presenting in advanced phase is defined mainly by blast count, but also by age, chromosomal aberrations and hemoglobin.
Am J Hematol
; 94(11): 1236-1243, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31456269
6.
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial.
Lancet Oncol
; 19(6): 747-757, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29735299
7.
Superoxide dismutase 2 (SOD2) contributes to genetic stability of native and T315I-mutated BCR-ABL expressing leukemic cells.
Biochem Biophys Res Commun
; 498(4): 715-722, 2018 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29550484
8.
Th-17 response and antimicrobial peptide expression are uniformly expressed in gastric mucosa of Helicobacter pylori-infected patients independently of their clinical outcomes.
Helicobacter
; 23(3): e12479, 2018 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-29582503
9.
Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study.
Cancer
; 123(10): 1791-1799, 2017 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28026860
10.
Additional cytogenetic abnormalities and variant t(9;22) at the diagnosis of childhood chronic myeloid leukemia: The experience of the International Registry for Chronic Myeloid Leukemia in Children and Adolescents.
Cancer
; 123(18): 3609-3616, 2017 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28497898
11.
Prognostic discrimination based on the EUTOS long-term survival score within the International Registry for Chronic Myeloid Leukemia in children and adolescents.
Haematologica
; 102(10): 1704-1708, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28838993
12.
Natural killer-cell counts are associated with molecular relapse-free survival after imatinib discontinuation in chronic myeloid leukemia: the IMMUNOSTIM study.
Haematologica
; 102(8): 1368-1377, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28522576
13.
Cultural adaptation of the female pelvic floor questionnaire (FPFQ) into French.
Neurourol Urodyn
; 36(2): 253-258, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26587906
14.
Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study.
Blood
; 124(15): 2408-10, 2014 Oct 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25170123
15.
Analyzing molecular response in chronic myeloid leukemia clinical trials: pitfalls and golden rules.
Cancer
; 121(4): 490-7, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25346428
16.
Oral CHOP-like chemotherapy in 60-80 years-old patients with diffuse large B-cell lymphoma.
Br J Haematol
; 186(6): e175-e178, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31309541
17.
Definitions, methodological and statistical issues for phase 3 clinical trials in chronic myeloid leukemia: a proposal by the European LeukemiaNet.
Blood
; 119(25): 5963-71, 2012 Jun 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-22508936
18.
Tolerability and efficacy of pegylated interferon-α-2a in combination with imatinib for patients with chronic-phase chronic myeloid leukemia.
Cancer
; 119(24): 4284-9, 2013 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24105694
19.
Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.
N Engl J Med
; 363(26): 2511-21, 2010 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-21175313
20.
Predicting complete cytogenetic response and subsequent progression-free survival in 2060 patients with CML on imatinib treatment: the EUTOS score.
Blood
; 118(3): 686-92, 2011 Jul 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21536864